{"id":"W4293555019","doi":"10.3332/ecancer.2022.ed124","title":"CDK 4/6 inhibitors for adjuvant therapy in early breast cancer—Do we have a clear winner?","year":2022,"lang":"en","type":"editorial","venue":"ecancermedicalscience","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"Government of Ontario","keywords":"Palbociclib; Medicine; Adjuvant; Breast cancer; Oncology; Cyclin-dependent kinase; Internal medicine; Cancer; Adjuvant therapy; Clinical trial; Pharmacology; Metastatic breast cancer; Cell cycle","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001423835,0.0009084402,0.001751061,0.0006659084,0.0004242159,0.0001050112,0.001347502,0.0008389943,0.002283172],"category_scores_gemma":[0.0007057174,0.0007987522,0.0004362414,0.001394379,0.001544189,0.0003928618,0.0003489892,0.002619631,0.00001750882],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003140513,"about_ca_system_score_gemma":0.006603423,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001951081,"about_ca_topic_score_gemma":0.0004432775,"domain_scores_codex":[0.991165,0.0001632663,0.001187843,0.002116539,0.003696048,0.00167129],"domain_scores_gemma":[0.9960124,0.0009472668,0.0007247402,0.001094696,0.0005160936,0.0007047363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004122457,0.0003516939,0.001367414,0.0003688693,0.0001180787,0.0001232646,0.002339023,0.0000878905,0.0003579716,0.00002823772,0.5756931,0.415042],"study_design_scores_gemma":[0.006917529,0.001451271,0.002491615,0.002212667,0.00007143628,0.00004426618,0.0005649991,0.000173682,0.0001243898,0.0005672037,0.9845406,0.0008403733],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.009989487,0.04128736,0.0002515192,0.01304498,0.9266387,0.004202592,0.003876091,0.0003683317,0.0003409268],"genre_scores_gemma":[0.02420624,0.03747106,0.0007207575,0.001339515,0.9258657,0.006234383,0.000228318,0.0004433038,0.003490685],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.4142016,"threshold_uncertainty_score":0.9996814,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01290050894898051,"score_gpt":0.3166935721001164,"score_spread":0.3037930631511359,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}